Factor V/Factor Va-targeting monoclonal antibodies (University of Pennsylvania/Children's Hospital of Philadelphia/Ionis Pharmaceuticals)

N/A

Report date: 2025/03/20 16:05:26

Base Information

Drug NameFactor V/Factor Va-targeting monoclonal antibodies (University of Pennsylvania/Children's Hospital of Philadelphia/Ionis Pharmaceuticals)
Drug Alias NameFactor V/Factor Va-targeting mAb (University of Pennsylvania/Children's Hospital of Philadelphia/Ionis Pharmaceuticals)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionFactor Va inhibitors
TargetsCoagulation factor V
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesChildrens Hospital of PhiladelphiaIonis Pharmaceuticals IncUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A